Literature DB >> 1433628

Diagnostic and therapeutic problems in multicentric renal angiomyolipoma.

C Tallarigo1, R Baldassarre, G Bianchi, L Comunale, G Olivo, M Pea, F Bonetti, G Martignoni, G Zamboni, G Mobilio.   

Abstract

Multicentric renal angiomyolipoma is a rare form of benign tumor. However, its effective incidence as evaluated in autopsy studies may be as high as 8%. There are 2 main types of renal angiomyolipoma, that is isolated forms and those associated with other diseases, such as phakomatosis, polycystic kidneys and fibromuscular dysplasia. The tumor may also display malignant behavior with local invasiveness and regional lymph node involvement. However, the clinical course is benign and multicentricity is important for prognosis. Histopathological diagnosis often is difficult. Immunohistochemical analysis of surgical specimens using a panel of monoclonal antibodies, including HMB-45 and actin, enabled us to make a definitive diagnosis in 3 cases of multicentric renal angiomyolipoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433628     DOI: 10.1016/s0022-5347(17)37057-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

2.  Transcatheter embolisation of renal angiomyolipoma.

Authors:  S Leong; A N Keeling; F P McGrath; M J Lee
Journal:  Ir J Med Sci       Date:  2009-07-18       Impact factor: 1.568

3.  A bladder wall angiomyolipoma as a manifestation of tuberous sclerosis: first case report.

Authors:  Mehmet Kalkan; Coşkun Sahin; Omer Etlik; Ergun Uçmaklı
Journal:  Case Rep Urol       Date:  2013-09-18

Review 4.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.